Otto Bock Patient Care LLC

Otto Bock Patient Care LLC, a foreign-owned medical device manufacturer based in Austin, Texas, supplies prosthetic limbs, orthotic braces, and related fabrication and fitting services to the Department of Veterans Affairs as a prime contractor across multiple Veterans Integrated Service Networks, competing full-and-open with no SBA set-aside designations on substantially all work.

Otto Bock operates exclusively as a prime contractor—359 recent awards carry zero subcontract activity—across 14 federal customer agencies with overwhelming concentration in the Veterans Health Administration. The top five VISNs by award count account for 83% of recent procurements: VISN 22 leads with 132 awards valued at $3.6 million combined potential, followed by VISN 19 (57 awards, $1.4 million), VISN 7 (50 awards, $1.1 million), VISN 4 (32 awards, $2.3 million), and VISN 17 (27 awards, $1 million). However, the dollar-value ranking diverges sharply. VISN 5 anchors the portfolio with just five awards but $43.9 million combined potential value—predominantly two indefinite delivery vehicles: a $29.448 million multiple-award IDIQ for artificial limbs and related services running through April 9, 2028, and a $14.4 million basic ordering agreement for orthotic devices through September 16, 2030. VISN 10 contributes seven awards worth $7.1 million (anchored by a $7 million single-award blanket purchase agreement for orthotics through September 21, 2030), and VISN 15 holds 24 awards valued at $7 million (supported by a $6.3 million single-award BPA). Combined potential value across all 359 awards totals $68.1 million; obligated dollars stand at $9.4 million (14% utilization), reflecting the heavy reliance on indefinite delivery vehicles that generate task orders as needed rather than full-value awards upfront.

Otto Bock's award footprint spans firm fixed-price purchase orders and BPA calls for discrete prosthetic devices and custom fabrication. Recent concrete examples include a $97,617.95 purchase order from VISN 17 (October 2025) for a comprehensive prosthetic order, a $116,768.41 VISN 22 order (August 2025) for artificial limbs, a $94,129.59 VISN 15 BPA call (July 2025) for a leg with Genium X4 microprocessor-controlled knee, a $157,159.16 VISN 22 order (July 2025) for prosthetic devices and services, and a $98,191.54 VISN 17 order (June 2025) for limb procurement. Below-threshold orders—the bulk of activity—typically value in the $10,000 to $30,000 range for individual sockets, below-knee or above-knee prostheses, transtibial or transfemoral devices, and repair or replacement services. The company holds positions on three foundational IDVs with VISN 5 (2023 award, $29.448 million through 2028, partial small business set-aside), VISN 5 BOA (September 2025, $14.4 million through 2030), and VISN 10 BPA (September 2025, $7 million through 2030). Task order activity under these vehicles cluster under Blanket Purchase Agreement 36C24421A0033 (23 task orders, $619 thousand combined) and 36C25522A0040 (18 task orders, $558 thousand combined), consistent with recurring VA procurement of specialized prosthetic components and custom-fitted devices across service networks.

Activity accelerated sharply: one award in 2022, 43 in 2023, 124 in 2024, 162 in 2025, and 28 year-to-date in 2026 (as of June 29). The 2023-to-2025 trajectory reflects Otto Bock's establishment as a recognized VA prosthetics vendor, with recurring task orders flowing under the VISN 5 IDIQ (awarded April 2023) and subsequent BPAs with VISN 15, VISN 10, and VISN 4. Fourteen awards with ultimate completion dates within the next twenty-four months carry combined potential value of $498 thousand—modest recompete exposure at the individual task-order level, though the two largest IDVs (VISN 5 IDIQ and BOA, totaling $43.848 million) extend through 2028 and 2030 respectively and represent core business continuity vehicles. The NAICS footprint is 91% Surgical Appliance and Supplies Manufacturing (NAICS 339113), with 9% Surgical and Medical Instrument Manufacturing (NAICS 339112); PSC coding is almost entirely Medical and Surgical Instruments, Equipment, and Supplies (358 of 359 awards).

Otto Bock faces no competition from set-aside-only vendors—all awards carry no set-aside designation. The firm competes full-and-open against other prosthetics manufacturers and orthotic device suppliers for VA task orders and BPA calls. Recent award summaries characterize Otto Bock as a "foreign-owned medical device provider" and "specialized supplier of prosthetic solutions," indicating recognition by VA contracting officers of technical specialization in prosthetic device design, fabrication, and customization. The company's commercial presence—headquarters in Austin, Texas, with performance locations spanning Dallas, San Antonio, Austin (Texas), Lebanon and Hanover (Pennsylvania), Columbia and Buford and Decatur (Georgia), Memphis (Tennessee), Marion (Illinois), St. Louis and Springfield (Missouri), and scattered other VA service areas—reflects a nationwide footprint aligned with VA regional medical center distribution.